A study from the University of Missouri has found that a compound in wine can be used to boost the effectiveness of radiation-based cancer therapy.
October 14/Colombia, Mo./RedOrbit -- Previous research has linked red wine to numerous health benefits, and a new study from the University of Missouri has found that a compound in the beverage can be used to boost the effectiveness of radiation-based cancer therapy.
In the study, the red-wine compound resveratrol was used to treat melanoma cells, resulting in 44% of the tumor cells being killed. When the melanoma was treated with both resveratrol and radiation, 65% of the tumor cells were killed.